当前位置:首页 - 行情中心 - 科伦药业(002422) - 财务分析 - 现金流量表

科伦药业

(002422)

  

流通市值:521.37亿  总市值:638.70亿
流通股本:12.99亿   总股本:15.91亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金15,649,850,30010,473,987,3254,888,740,13421,640,073,663
  收到的税费返还216,073,900182,119,80029,260,900229,778,400
  收到其他与经营活动有关的现金907,660,138849,983,55592,026,541510,339,607
  经营活动现金流入小计16,773,584,33811,506,090,6805,010,027,57522,380,191,670
  购买商品、接受劳务支付的现金7,696,558,1174,716,828,3622,434,260,99911,438,946,661
  支付给职工以及为职工支付的现金2,948,795,7982,075,725,7971,212,096,1153,588,802,394
  支付的各项税费1,571,987,3001,113,264,500486,913,0802,365,767,100
  支付其他与经营活动有关的现金1,819,683,7561,259,100,111627,146,0642,344,607,230
  经营活动现金流出小计14,037,024,9719,164,918,7704,760,416,25819,738,123,385
  经营活动产生的现金流量净额2,736,559,3672,341,171,910249,611,3172,642,068,285
二、投资活动产生的现金流量:
  收回投资收到的现金17,198,922,57811,642,117,7567,730,308,00024,252,576,164
  取得投资收益收到的现金181,041,038101,088,96723,123,290170,522,117
  处置固定资产、无形资产和其他长期资产收回的现金净额1,980,2841,828,3451,447,69210,803,354
  处置子公司及其他营业单位收到的现金净额10,800,00010,800,000-11,898,478
  投资活动现金流入小计17,392,743,90011,755,835,0687,754,878,98224,445,800,113
  购建固定资产、无形资产和其他长期资产支付的现金940,764,767674,567,233412,297,3611,622,489,729
  投资支付的现金19,468,690,04413,471,430,8768,136,936,72024,109,216,400
  取得子公司及其他营业单位支付的现金---2,354,956
  投资活动现金流出小计20,409,454,81114,145,998,1098,549,234,08125,734,061,085
  投资活动产生的现金流量净额-3,016,710,911-2,390,163,041-794,355,099-1,288,260,972
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,370,748,46611,787,398-1,797,570,052
  其中:子公司吸收少数股东投资收到的现金2,370,748,46611,787,398-1,797,570,052
  取得借款收到的现金4,169,545,0233,532,109,6852,121,267,8244,656,527,844
  收到其他与筹资活动有关的现金1,581,173,8731,434,392,684483,704,507348,446,573
  筹资活动现金流入小计8,121,467,3624,978,289,7672,604,972,3316,802,544,469
  偿还债务支付的现金3,897,179,7682,595,950,6951,506,370,5544,671,387,976
  分配股利、利润或偿付利息支付的现金992,646,690984,074,76314,344,2641,331,140,752
  其中:子公司支付给少数股东的股利、利润207,614,032207,614,032-240,433,226
  支付其他与筹资活动有关的现金1,875,945,2961,135,276,11537,948,075115,986,460
  筹资活动现金流出小计6,765,771,7544,715,301,5731,558,662,8936,118,515,188
  筹资活动产生的现金流量净额1,355,695,608262,988,1941,046,309,438684,029,281
四、汇率变动对现金及现金等价物的影响-67,949-4,887,003-806,895-45,926,939
五、现金及现金等价物净增加额1,075,476,115209,110,060500,758,7611,991,909,655
  加:期初现金及现金等价物余额5,936,671,7295,936,671,7295,936,671,7293,944,762,074
  期末现金及现金等价物余额7,012,147,8446,145,781,7896,437,430,4905,936,671,729
补充资料:
  净利润-1,426,262,565-1,877,211,208
  资产减值准备-81,454,853-139,725,774
  固定资产和投资性房地产折旧-622,946,410-1,196,978,097
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-622,946,410-1,196,978,097
  无形资产摊销-67,118,525-126,597,495
  长期待摊费用摊销-15,943,409-20,468,303
  处置固定资产、无形资产和其他长期资产的损失--1,680,587--5,320,176
  固定资产报废损失-6,139,738-11,010,245
  公允价值变动损失--18,418,112--27,611,838
  财务费用-61,553,579-148,403,066
  投资损失--117,208,645--210,412,627
  递延所得税--23,982,672--13,121,354
  其中:递延所得税资产减少-22,812,112--32,226,652
    递延所得税负债增加--46,794,784-19,105,298
  存货的减少--50,925,916--158,490,254
  经营性应收项目的减少-56,887,188--37,968,987
  经营性应付项目的增加-15,213,591--676,416,316
  其他-166,788,574-174,673,294
  现金的期末余额-6,145,781,789-5,936,671,729
  减:现金的期初余额-5,936,671,729-3,944,762,074
  现金及现金等价物的净增加额-209,110,060-1,991,909,655
公告日期2026-10-292026-08-272026-04-292026-04-03
审计意见(境内)标准无保留意见
TOP↑